Is COMISA another opportunity for use of incretin drugs?

Allan I. Pack; Ronald Grunstein; Babak Mokhlesi; Silke Ryan; Richard Schwab; David Gozal

doi:10.1093/sleep/zsaf254

Is COMISA another opportunity for use of incretin drugs?

Allan I. Pack^*, Ronald Grunstein, Babak Mokhlesi, Silke Ryan, Richard Schwab, David Gozal

^*Corresponding author for this work

Macquarie Medical School

Research output: Contribution to journal › Letter › peer-review

Original language	English
Article number	zsaf254
Pages (from-to)	1-2
Number of pages	2
Journal	Sleep
Volume	48
Issue number	11
DOIs	https://doi.org/10.1093/sleep/zsaf254
Publication status	Published - 10 Nov 2025

Keywords

GLP-1 agonists
Incretins
Insomnia
Obstructive sleep apnea

Access to Document

10.1093/sleep/zsaf254

Cite this

@article{f519e07895b14bd1bbadae001e329e9a,

title = "Is COMISA another opportunity for use of incretin drugs?",

keywords = "GLP-1 agonists, Incretins, Insomnia, Obstructive sleep apnea",

author = "Pack, \{Allan I.\} and Ronald Grunstein and Babak Mokhlesi and Silke Ryan and Richard Schwab and David Gozal",

year = "2025",

month = nov,

day = "10",

doi = "10.1093/sleep/zsaf254",

language = "English",

volume = "48",

pages = "1--2",

journal = "Sleep",

issn = "0161-8105",